Citation: Gm. Hanna, DETERMINATION OF ENANTIOMERIC COMPOSITION OF IBUPROFEN IN BULK DRUG BY PROTON NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY WITH A CHIRAL LANTHANIDE CHELATE, Journal of pharmaceutical and biomedical analysis, 15(12), 1997, pp. 1805-1811
Citation: Gm. Hanna et Ca. Laucam, SIMPLE H-1-NMR SPECTROSCOPIC METHOD FOR ASSAY OF SALTS OF THE CONTRAST AGENT DIATRIZOATE IN COMMERCIAL SOLUTIONS, Journal of AOAC International, 79(4), 1996, pp. 833-838
Citation: Gm. Hanna, DETERMINATION OF EPHEDRINE, PSEUDOEPHEDRINE, AND NOREPHEDRINE IN MIXTURES (BULK AND DOSAGE FORMS) BY PROTON NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY, Journal of AOAC International, 78(4), 1995, pp. 946-954
Citation: Gm. Hanna, PROTON NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPIC DETECTION AND DETERMINATION OF ETHYLENE-GLYCOL DIMETHACRYLATE AS A CONTAMINANT OF METHYL-METHACRYLATE RAW-MATERIAL, Journal of AOAC International, 78(4), 1995, pp. 954-958
Citation: Gm. Hanna et Ca. Laucam, DETERMINATION OF THE OPTICAL PURITY OF TIMOLOL MALEATE BY PROTON NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY WITH A CHIRAL PR(III) SHIFT-REAGENT, Journal of pharmaceutical and biomedical analysis, 13(11), 1995, pp. 1313-1319
Citation: Gm. Hanna et Ca. Laucam, STABILITY-INDICATING PROTON NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPIC ASSAY-METHOD FOR FUROSEMIDE IN TABLETS AND INJECTIONS, Journal of AOAC International, 76(3), 1993, pp. 526-530
Citation: Gm. Hanna et Ca. Laucam, DETERMINATION OF CHLORPHENIRAMINE MALEATE IN TABLETS AND INJECTIONS BY H-1-NMR SPECTROSCOPY, Journal of pharmaceutical and biomedical analysis, 11(9), 1993, pp. 855-859
Citation: Gm. Hanna et Ca. Laucam, DETERMINATION OF THE OPTICAL PURITY AND ABSOLUTE-CONFIGURATION OF THREO-METHYLPHENIDATE BY PROTON NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY WITH CHIRAL SOLVATING AGENT, Journal of pharmaceutical and biomedical analysis, 11(8), 1993, pp. 665-670